Nordic Consortium for Acute Type a Aortic Dissection-2

NCT06862583 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2025-03-06

No results posted yet for this study

Summary

The Nordic Consortium for Acute Type A Aortic Dissection-2 (NORCAAD-2) is a multicenter research collaboration involving up to 19 units in the Nordic countries and one in The Netherlands. All patients referred for this condition is included, to outline detailed preoperative characteristics and risk factors as well as, for those operated, data on the operative procedure, the postoperative course including major and minor complications and, as the primary interest, mortality in short- and long-term perspective. The need for further procedures on the aorta will also be studied.

Acute type A Aortic Dissection (ATAAD) is a vascular emergency with very high case-fatality rate. The condition is realtively infrequent, and single units can rarely amass sufficient number of patients during a reasonable time to analyse also unusual variants in background, presentation, and management. Randomized controlled trials are unlikely, and large multicenter databases are the best source of knowledge for the foreseeable future. Other such databases exist, but NORCAAD-2 is more focused (only ATAAD) and more detailed than many counterparts, with the ability to extract unique information.

NORCAAD-2 is the extension and expansion of the original NORCAAD project. NORCAAD-2 includes more centers, more patients, more data and utilizes a novel on-line common database designed for the purpose.

The ultimate goal is to identify novel risk markers to help inform decisions on pre-emptive surgery (before ATAAD occurs); to outline superior perioperative techniques and strategies to optimize outcomes both short- and long-term; and to analyze variables related to major complications, in an effort to further reduce their incidence.

Conditions

  • Aortic Dissection

Interventions

PROCEDURE

surgery

Open heart surgery

PROCEDURE

endovascular intervention

Aortic endovascular intervention

Sponsors & Collaborators

  • Aarhus University Hospital Skejby

    collaborator OTHER
  • Haukeland University Hospital

    collaborator OTHER
  • Rigshospitalet, Denmark

    collaborator OTHER
  • Helsinki University Central Hospital

    collaborator OTHER
  • Kuopio University Hospital

    collaborator OTHER
  • Leiden University Medical Center

    collaborator OTHER
  • Skane University Hospital

    collaborator OTHER
  • Odense University Hospital

    collaborator OTHER
  • Oslo University Hospital

    collaborator OTHER
  • Landspitali University Hospital

    collaborator OTHER
  • Norrlands University Hospital

    collaborator OTHER
  • Tampere University Hospital

    collaborator OTHER
  • Turku University Hospital

    collaborator OTHER_GOV
  • Trondheim University Hospital

    collaborator OTHER
  • University Hospital, Linkoeping

    collaborator OTHER
  • Vastra Gotaland Region

    collaborator OTHER_GOV
  • Uppsala University Hospital

    collaborator OTHER
  • Blekinge County Council Hospital

    collaborator OTHER
  • Örebro University, Sweden

    collaborator OTHER
  • Karolinska Institutet

    lead OTHER

Principal Investigators

  • Christian Olsson, MD, PhD · Karolinska Institutet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-03
Primary Completion
2029-06-30
Completion
2030-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06862583 on ClinicalTrials.gov